Elevated Levels of Toxic Belladonna Found in Infant Teething Remedies — Physician’s First Watch

Medical News |
January 30, 2017

Elevated Levels of Toxic Belladonna Found in Infant Teething Remedies

By Kristin J. Kelley

Edited by Susan Sadoughi, MD, and André Sofair, MD, MPH

The FDA has confirmed that homeopathic teething tablets marketed by Hyland's contain elevated amounts of the toxic substance belladonna (deadly nightshade) and is warning consumers not to use them.

Parents should get immediate medical care for their infants and children if they experience symptoms of belladonna toxicity — which include agitation, difficulty breathing, lethargy, muscle weakness, seizures, skin flushing, and constipation — while taking the medication. Belladonna has an anticholinergic effect.

Homeopathic teething products are not approved by the FDA, nor have they been evaluated for safety. Three products containing belladonna were recalled by Rarity Pharmaceuticals this past November. The agency first recommended against Hyland's tablets, manufactured by the Standard Homeopathic Company, in 2010.

The manufacturer has not agreed to a recall, says the FDA, but a letter to consumers on the Hyland's website notes that their teething products are no longer being distributed in the U.S.

Your Comment

(will not be published)

Filtered HTML

  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Do you have any conflict of interest to disclose?
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

* Required

Reader comments are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.